Hanata, N.; Nagafuchi, Y.; Sugimori, Y.; Kobayashi, S.; Tsuchida, Y.; Iwasaki, Y.; Shoda, H.; Fujio, K.
Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy. J. Clin. Med. 2021, 10, 3730.
https://doi.org/10.3390/jcm10163730
AMA Style
Hanata N, Nagafuchi Y, Sugimori Y, Kobayashi S, Tsuchida Y, Iwasaki Y, Shoda H, Fujio K.
Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy. Journal of Clinical Medicine. 2021; 10(16):3730.
https://doi.org/10.3390/jcm10163730
Chicago/Turabian Style
Hanata, Norio, Yasuo Nagafuchi, Yusuke Sugimori, Satomi Kobayashi, Yumi Tsuchida, Yukiko Iwasaki, Hirofumi Shoda, and Keishi Fujio.
2021. "Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy" Journal of Clinical Medicine 10, no. 16: 3730.
https://doi.org/10.3390/jcm10163730
APA Style
Hanata, N., Nagafuchi, Y., Sugimori, Y., Kobayashi, S., Tsuchida, Y., Iwasaki, Y., Shoda, H., & Fujio, K.
(2021). Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy. Journal of Clinical Medicine, 10(16), 3730.
https://doi.org/10.3390/jcm10163730
